Drug intelligence / Profile preview

vax-MEN-ACW135

Development stage: Unknown
Lead developer: Finlay Vaccine Institute
Modality: Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

vax-MEN-ACW135 is a trivalent polysaccharide vaccine developed by the Finlay Vaccine Institute for the prevention of meningococcal disease. It is designed to provide protection against *Neisseria meningitidis* serogroups A, C, and W135. The vaccine works by introducing purified capsular polysaccharides from these specific serogroups, which act as antigens to stimulate the host's immune system to produce protective bactericidal antibodies. It is primarily indicated for active immunization in individuals at risk of infection by these serogroups and is currently approved for use in regions where these serogroups are prevalent.

Brand names: vax-MEN-ACW135vax-MEN-ACW-135vax-MEN-ACW 135vax-MEN-ACW®135
Other names: meningococcal polysaccharide vaccine (groups A, C, W135)trivalent meningococcal polysaccharide vaccine

Targets

Neisseria meningitidis group C capsular polysaccharideNmA CPS (Neisseria meningitidis group A capsular polysaccharide)MenW CPS (Neisseria meningitidis serogroup W capsular polysaccharide)

Beyond the preview

Go deeper on vax-MEN-ACW135.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on vax-MEN-ACW135.

Explore the full profile